- Home
- Industry Reports
- Biotechnology
- Healthcare
- Europe Biobanks Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Biobank is a collection of biological, tissues, samples and medical data for the purpose of research. Biobanks play a vital role in drug discovery and disease research. EuropeBiobanks Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.
Europe Biobanks Market Share:
Europe Biobanks market is segmented by product, samples, application, and geography. On basics of sample, human tissues have the largest share is in Europe especially in Germany for the betterment of the healthcare and demand for tissue, stem cell banking increased the share of Europe biobanks market.
Europe Biobanks Market Size:
Raising blood-related disorders, raise in research on human tissues, genes and drugs have driven the marketplace for biobanks in Europe. In the forecast period, North America and Asia-Pacific are going to have the highest growth rate in the market.
Europe Biobanks Market Growth:
The Europe biobanks market is driven by factors such as low productivity rate of the pharmaceutical industry, personalized medicine; biopreservation systems, new drugs development, and biobank methodology are favouring the overall growth of the biobanks market.
Europe Biobanks Market Industrial Analysis:
Europe BiobankMarket is segmented on the basis of product, sample, applications, and geography. In this classification, the growth of the market is driven by sample segment classified into biological fluids, human tissues, blood products and human waste. In the forecast period, Asia-Pacific is expected to grow at a quick pace.
Europe Biobanks Market Outlook:
Europe Biobanks are primarily used to reduce the side effects of drugs, personal medication, and research on human tissues, cells, and genes for instance, in research and drug development further increased the demand for biobanks across various research verticals and it’s predominant in Europe especially in Germany.
Europe Biobanks Market Trends:
Brooks Automation, Inc. has acquired Life Sciences Consumables provider on October 2017and known as Brooks Life Sciences.
Qiagen, bioinformatics has acquired Omic Soft Corporation providing access to multi-omics database in January 2017.
Biobanks Market Research Reports Includes
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analyzed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROCin the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
- Expertise investment opportunities by the analyst to the individual and organization to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
- Sigma-Aldrich
- deCODE Genetics, Inc.
- Metanomics Health
- Lifeline Scientific
- Qiagen N.V.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation byProduct
6.1 Consumables
6.2Services
6.3 Equipment
6.3.1 Incubators
6.3.2 Temperature control systems
6.3.3 Monitoring systems
6.4Software
Chapter 7 Market Segmentation by Sample
7.1 Biological Fluids
7.2 Human Tissues
7.3Blood Products
7.4Others
Chapter 8 Market Segmentation by Application
8.1Drug Discovery
8.2Therapeutic Application
8.3Disease Research
8.4 Others
Chapter 9 Market Segmentation by Geography
9.1 Europe
9.1.1 Introduction
9.1.2 Spain
9.1.3 UK
9.1.4 France
9.1.5 Russia
9.1.6 Italy
9.1.7 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1Brooks Life Science
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 Panasonic Biomedical
11.3 Beckman Coulter
11.4 WAK-Chemie Medical GmbH
11.5Thermo Fisher Scientific Inc.
11.6 Sigma-Aldrich
11.7deCODE Genetics, Inc.
11.8 Metanomics Health
11.9Lifeline Scientific
11.10 Cell & Co Biorepository
11.11 Integrated Biobank of Luxembourg
11.12 Tecan group
11.13 Qiagen N.V.
11.14DNA Genotek
11.15Askion
Chapter 12 Market Estimates and Forecasting
12.1 Market Estimates and Forecasting 2018-2024(USD Million)
12.1.1 Market Estimation and Forecasting by Product 2018-2024 (USD Million)
12.1.2 Market Estimation and Forecasting by Sample 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecasting by Application 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
12.1.5 Market Estimates and Forecasting by Company 2018-2024 (USD Million)
Chapter 13Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,988.77 - €6,629.22
- INR: ₹179,926.75 - ₹599,755.82
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,701.35 - £5,671.17
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Biobank is a collection of biological, tissues, samples and medical data for the purpose of research. Biobanks play a vital role in drug discovery and disease research. EuropeBiobanks Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.
Europe Biobanks Market Share:
Europe Biobanks market is segmented by product, samples, application, and geography. On basics of sample, human tissues have the largest share is in Europe especially in Germany for the betterment of the healthcare and demand for tissue, stem cell banking increased the share of Europe biobanks market.
Europe Biobanks Market Size:
Raising blood-related disorders, raise in research on human tissues, genes and drugs have driven the marketplace for biobanks in Europe. In the forecast period, North America and Asia-Pacific are going to have the highest growth rate in the market.
Europe Biobanks Market Growth:
The Europe biobanks market is driven by factors such as low productivity rate of the pharmaceutical industry, personalized medicine; biopreservation systems, new drugs development, and biobank methodology are favouring the overall growth of the biobanks market.
Europe Biobanks Market Industrial Analysis:
Europe BiobankMarket is segmented on the basis of product, sample, applications, and geography. In this classification, the growth of the market is driven by sample segment classified into biological fluids, human tissues, blood products and human waste. In the forecast period, Asia-Pacific is expected to grow at a quick pace.
Europe Biobanks Market Outlook:
Europe Biobanks are primarily used to reduce the side effects of drugs, personal medication, and research on human tissues, cells, and genes for instance, in research and drug development further increased the demand for biobanks across various research verticals and it’s predominant in Europe especially in Germany.
Europe Biobanks Market Trends:
Brooks Automation, Inc. has acquired Life Sciences Consumables provider on October 2017and known as Brooks Life Sciences.
Qiagen, bioinformatics has acquired Omic Soft Corporation providing access to multi-omics database in January 2017.
Biobanks Market Research Reports Includes
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analyzed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROCin the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
- Expertise investment opportunities by the analyst to the individual and organization to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
- Sigma-Aldrich
- deCODE Genetics, Inc.
- Metanomics Health
- Lifeline Scientific
- Qiagen N.V.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation byProduct
6.1 Consumables
6.2Services
6.3 Equipment
6.3.1 Incubators
6.3.2 Temperature control systems
6.3.3 Monitoring systems
6.4Software
Chapter 7 Market Segmentation by Sample
7.1 Biological Fluids
7.2 Human Tissues
7.3Blood Products
7.4Others
Chapter 8 Market Segmentation by Application
8.1Drug Discovery
8.2Therapeutic Application
8.3Disease Research
8.4 Others
Chapter 9 Market Segmentation by Geography
9.1 Europe
9.1.1 Introduction
9.1.2 Spain
9.1.3 UK
9.1.4 France
9.1.5 Russia
9.1.6 Italy
9.1.7 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1Brooks Life Science
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 Panasonic Biomedical
11.3 Beckman Coulter
11.4 WAK-Chemie Medical GmbH
11.5Thermo Fisher Scientific Inc.
11.6 Sigma-Aldrich
11.7deCODE Genetics, Inc.
11.8 Metanomics Health
11.9Lifeline Scientific
11.10 Cell & Co Biorepository
11.11 Integrated Biobank of Luxembourg
11.12 Tecan group
11.13 Qiagen N.V.
11.14DNA Genotek
11.15Askion
Chapter 12 Market Estimates and Forecasting
12.1 Market Estimates and Forecasting 2018-2024(USD Million)
12.1.1 Market Estimation and Forecasting by Product 2018-2024 (USD Million)
12.1.2 Market Estimation and Forecasting by Sample 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecasting by Application 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
12.1.5 Market Estimates and Forecasting by Company 2018-2024 (USD Million)
Chapter 13Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.